Skip to Main Content

Disease models

We aim to make disease models accessible to the worldwide research community. To that end, we acquire, develop, and characterize new models, and distribute them through public repositories.

Models currently available include cell lines and several types of xenograft models representing many of the clinical manifestations of the disease. This includes models derived from primary, recurrent, and metastatic tumors of multiple anatomic locations from children and adults.

Importantly, all models available from our repositories are rigorously characterized to ensure that they are actually derived from chordoma tumors and are properly identified.

Access to model sequencing data

Data resulting from genomic characterization of our cell lines and PDX models is available in Cavatica. To access this data, create an account, log in, and submit a data access request. Contact us if you need assistance. Processed and easily queryable model sequencing data is also available in PedcBioPortal.

Cell line repository

We partner with the American Type Culture Collection (ATCC) to maintain and distribute chordoma cell lines through their global distribution channels. Many of these cell lines are available through ATCC’s General Collection and may be purchased on the ATCC website. For cell lines that cannot be made available through ATCC’s General Collection, we maintain a private repository at ATCC; cell lines in this collection are available via a material transfer agreement with the Chordoma Foundation.

See the table below for details on available cell lines and how they can be obtained. Click the name of a cell line for more details including clinical data and culture instructions.

To request cell lines requiring an MTA, contact us. Requests involving multiple disease models that use identical MTA terms (such as U-CH or UM-Chor cell lines) may be consolidated into a single MTA document. In such cases, please specify each model requested in the draft MTA.

ATCC

Disease Origin

Disease Status

Age

Availability

Sacral

Recurrent

56

Sacral

Recurrent

72

Sacral

Recurrent + Metastatic

56

Sacral

Primary

67

Sacral

Primary

71

Sacral

Recurrent

75

Sacral

Primary

83

Sacral

Metastatic

38

Sacral

Metastatic

38

Sacral

Metastatic

38

Sacral

Metastatic

38

Thoracic

Recurrent + Metastatic

56

Available soon

Sacral

Primary

77

Available soon

Sacral

Recurrent + Metastatic

56

Sacral

Primary

61

Sacral

Recurrent

57

Clival

Primary

72

Clival

Primary

79

Clival

Primary

66

Clival

Primary

<20

Clival

Recurrent + Metastatic

<20

Clival

Recurrent + Metastatic

<20

Clival

Primary

32

Available soon

Clival

Recurrent + Metastatic

<20

Available soon

Clival

Recurrent + Metastatic

<20

Available soon

PDX repository

We partner with the contract research organization XenoSTART in San Antonio, TX to maintain and distribute cell line-derived xenograft (CDX) and patient-derived xenograft (PDX) models of chordoma. Currently available PDX models are listed below. Click the name of the model for more details including clinical data and culture instructions.

To request models contact us. Requests involving multiple disease models that use identical MTA terms (CF or SF PDX models) may be consolidated into a single MTA document. In such cases, please specify each model requested in the draft MTA.

In addition to the PDX models listed below, cell line derived xenograft models have been developed from the U-CH1 and CH22 cell lines. A humanized model of the U-CH1 cell line has also been developed. Contact us for more information.

Acknowledgements

We are deeply grateful to the patients who donated their tumor tissue from which these models are derived, to the researchers who painstakingly created them, and to the many donors who have contributed to making them available to the research community.

ATCC

Disease origin

Disease status

Age

Availability

Clival

Recurrent

59

Clival

Recurrent

42

Clival

Recurrent + Metastatic

<20

Clival

Recurrent + Metastatic

<20

Clival

Recurrent + Metastatic

57

Clival

Primary

<20

Clival

Recurrent + Metastatic

<20

Clival

Recurrent + Metastatic

<20

Clival

Recurrent + Metastatic

<20

Clival

Primary

55

Lumbar

Recurrent + Metastatic

58

Clival

Primary

61

Subscribe to the latest research advances

To stay up to date about the latest advances in chordoma science, be notified of new funding opportunities, and learn about additional resources that become available to you, sign up for our newsletter.